Publications Abelacimab Thromboembolic disorders are a major cause of morbidity and … Read Publication Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System WIth Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes Read Publication A Critical Review of the Efficacy and Safety of Inclisiran Read Publication A Review on the Efficacy and Safety of Oral Semaglutide Read Publication A prospective, multicenter, international study to explore the effect of three different amplitude settings in female subjects with urinary urge incontinence receiving interstim therapy Read Publication Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes Read Publication Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention Read Publication A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia Read Publication Tirzepatide: Summary of the Emerging Data on the Novel GLP-1/GIP Dual Agonist Read Publication Praliciguat Read Publication Efpeglenatide Read Publication Filipino-American Lipid Trial Read Publication Aliskiren and valsartan combination therapy for the management of hypertension Read Publication Carvedilol Reduces Aortic Wave Reflection and Improves Left Ventricular⁄Vascular Coupling: A Comparison With Atenolol Read Publication Newer Agents for the Management of Overactive Bladder Read Publication Obesity and the Risk of Heart Failure Read Publication Less RAAS is more, or not Read Publication Mycobacterium tuberculosis H37Rv: In Silico Drug Targets Identification by Metabolic Pathways Analysis Read Publication Selective detection of Mg2+ ions via enhanced fluorescence emission using Au–DNA nanocomposites Read Publication Management of hypertension with fixed-dose triple-combination treatments Read Publication SGLT-2 inhibitors and their potential in the treatment of diabetes Read Publication Tofogliflozin: A Highly Selective SGLT2 Inhibitor For Treatment Of Type 2 Diabetes Read Publication Advances in Myocardial Infarction Managment https://www.futuremedicine.com/doi/abs/10.2217/ebo.12.428 Read Publication Baseline predictors of central aortic blood pressure: A PEAR substudy Read Publication
